ArticleFrontiers in immunology2026
Single-cell profiling uncovers extracellular vesicle-associated malignant plasma cell subpopulations driving multiple myeloma progression.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple myeloma (MM) is a heterogeneous hematological malignancy characterized by the clonal proliferation of plasma cells in the bone marrow, with distinct subtypes including smoldering MM (SMM), newly diagnosed MM (NDMM), and relapsed/refractory MM (RRMM). Despite therapeutic advances, outcomes remain unsatisfactory, especially for RRMM, due to unclear heterogeneity, progression mechanisms, and crosstalk between tumor cells and the bone marrow microenvironment (BMME) via direct interactions or extracellular vesicles (EVs). Methods: Single-cell RNA sequencing (scRNA-seq) was performed on bone marrow samples from 12 MM patients, and major cell types were identified. Plasma cells were subjected to re-clustering to explore subpopulation heterogeneity. Functional enrichment analysis of differentially expressed genes (DEGs) was conducted. Cellular stemness was evaluated by CytoTRACE, and developmental trajectories were inferred via Monocle and Slingshot. Cell-cell communication was analyzed by CellChat, while transcription factor (TF) regulatory networks were identified through SCENIC analysis. Metabolic pathway activity was also assessed. Finally, loss-of-function experiments (siRNA-mediated ASS1 knockdown) were conducted to validate its functional role. Results: The analysis identified 7 major cell types. Plasma cells were further stratified into 6 subpopulations (C0- Conclusion: Our study delineates MM heterogeneity, developmental dynamics, and regulatory networks at the single-cell level.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.